Filing Flows › Bio Key International (BKYI) › Q1 2026 › vs Q1 2025
Bio Key International (BKYI) Q1 2026 vs Q1 2025 (year over year)
Bio Key International's revenue rose $538K (+33%) from $1.6M in Q1 2025 to $2.1M in Q1 2026. The biggest changes: Hardware +$295K (+125%); License +$267K (+24%); Service −$24K (-9%).
Bio Key International, Q1 2026: revenue $2.1M (+34% year over year), operating margin -7.4%, net loss $205K, operating cash flow −$358K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| License | $1.4M | $1.1M | $267K | +24% |
| Hardware | $531K | $236K | $295K | +125% |
| Service | $248K | $273K | −$24K | -9% |
| Revenue | $2.1M | $1.6M | $538K | +33% |
| Net loss | $205K | $737K | −$532K | -72% |
| Costs & expenses | $2.4M | $2.3M | $7K | +0.3% |
| Operating costs | $2.3M | $2.2M | $55K | +2% |
| Interest & other, net | $47K | $96K | −$49K | -51% |
| Cost of revenue | $376K | $279K | $97K | +35% |
| Research & development | $617K | $596K | $21K | +4% |
| SG&A | $1.3M | $1.4M | −$62K | -5% |
| Operating cash sources | $470K | $986K | −$516K | -52% |
| Depreciation & amortization | $71K | $98K | −$27K | -28% |
| Share-based compensation | $41K | $52K | −$12K | -22% |
| Cash used in operations | $358K | $835K | −$477K | -57% |
| Net loss absorbed | $205K | $737K | −$532K | -72% |
| Working capital & other | $264K | $249K | $15K | +6% |
Questions
How much did Bio Key International's revenue grow year over year in Q1 2026?
Bio Key International's revenue rose $538K (+33%) from $1.6M in Q1 2025 to $2.1M in Q1 2026.
What drove Bio Key International's revenue change in Q1 2026?
Hardware +$295K (+125%); License +$267K (+24%); Service −$24K (-9%).